» Authors » Matthias Goebeler

Matthias Goebeler

Explore the profile of Matthias Goebeler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 279
Citations 2696
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cramer N, Kromer D, Bootsveld J, Sennhenn-Kirchner S, Gerdes S, Sondermann W, et al.
J Dtsch Dermatol Ges . 2025 Feb; PMID: 39955732
Background And Objectives: Mucosal lichen planus (LP) is a chronic inflammatory disease. The patient's journey can be arduous as diagnosis and therapy are challenging. Patients And Methods: In this cross-sectional...
2.
Haggenmuller S, Wies C, Abels J, Winterstein J, Heinlein L, Nogueira Garcia C, et al.
Nat Commun . 2025 Jan; 16(1):789. PMID: 39824857
Accurate melanoma diagnosis is crucial for patient outcomes and reliability of AI diagnostic tools. We assess interrater variability among eight expert pathologists reviewing histopathological images and clinical metadata of 792...
3.
Azeem M, Helal M, Klein-Hessling S, Serfling E, Goebeler M, Muhammad K, et al.
J Invest Dermatol . 2024 Dec; PMID: 39733935
A plethora of data supports a major role of CD4 and CD8 T lymphocytes for the initiation, progression, and maintenance of allergic contact dermatitis. However, in-depth understanding of the molecular...
4.
Dege T, Rutten A, Goebeler M, Kneitz H
Dermatopathology (Basel) . 2024 Dec; 11(4):348-353. PMID: 39727619
Digital papillary adenocarcinoma (DPAC) is a rare, low-grade sweat gland carcinoma primarily found on the hands, fingers, or toes and predominantly affecting males. Distinguishing DPAC from benign sweat gland tumors...
5.
Glutsch V, Schummer P, Goebeler M, Gesierich A, Schilling B
Front Immunol . 2024 Dec; 15:1495004. PMID: 39703511
Background: Merkel cell carcinoma (MCC) is a rare but highly aggressive cutaneous malignancy. Immune checkpoint inhibition (ICI) with PD-(L)1 blockade has significantly improved treatment outcomes in metastatic disease. In patients...
6.
Tischler S, Trautmann A, Goebeler M, Stoevesandt J
J Allergy Clin Immunol Pract . 2024 Nov; 13(1):79-88.e4. PMID: 39505106
Background: Venom-allergic patients are frequently double-sensitized to honeybee venom (BV) and Vespula venom (VV). Genuine double allergy is uncommon. Objectives: To assess whether a quantitative comparison of BV- and VV-specific...
7.
Heinlein L, Maron R, Hekler A, Haggenmuller S, Wies C, Utikal J, et al.
Commun Med (Lond) . 2024 Sep; 4(1):177. PMID: 39256516
Background: Early detection of melanoma, a potentially lethal type of skin cancer with high prevalence worldwide, improves patient prognosis. In retrospective studies, artificial intelligence (AI) has proven to be helpful...
8.
Fleissner J, Ickrath K, Goebeler M, Benoit S, Kerstan A
Acta Derm Venereol . 2024 Sep; 104:adv40627. PMID: 39248294
No abstract available.
9.
Zvulunov A, Neale H, Stern J, Santaguida P, Buros Stein A, Koh M, et al.
J Am Acad Dermatol . 2024 Aug; 91(6):1078-1085. PMID: 39181404
Background: Pediatric Mycosis fungoides (MF) management extrapolates from adult guidelines, despite differing clinical aspects. Recommendations are essential to address unique challenges in this distinct patient group. Objective: This project aims...
10.
Wobser M, Appenzeller S, Roth S, Siedel C, Goebeler M, Geissinger E, et al.
Br J Dermatol . 2024 Jun; 191(5):816-822. PMID: 38924750
Background: Primary cutaneous acral CD8+ T-cell lymphoproliferative disorder (TLPD) is a rare and indolent lymphoma entity. Although TLPD was first identified many years ago, the molecular pathogenesis is still not...